Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ LDLRAD4 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA565879
Description
Immunogen sequence: HYKVSTRSFIN RPNQSRRRED GLPQEGCLWP SDSAAPRLGA SEIMHAPRSR DRFTAPSFIQ RDRFSRFQ Highest antigen sequence identity to the following orthologs - mouse 81%, rat 81%.
Functions as a negative regulator of TGF-beta signaling and thereby probably plays a role in cell proliferation, differentiation, apoptosis, motility, extracellular matrix production and immunosuppression. In the canonical TGF-beta pathway, ZFYVE9/SARA recruits the intracellular signal transducer and transcriptional modulators SMAD2 and SMAD3 to the TGF-beta receptor. Phosphorylated by the receptor, SMAD2 and SMAD3 then form a heteromeric complex with SMAD4 that translocates to the nucleus to regulate transcription. Through interaction with SMAD2 and SMAD3, LDLRAD4 may compete with ZFYVE9 and SMAD4 and prevent propagation of the intracellular signal.
Specifications
LDLRAD4 | |
Polyclonal | |
Unconjugated | |
LDLRAD4 | |
8230401C20Rik; A430083H02; A430108L08Rik; C18orf1; clone 22; D18Ertd653e; D330030L18Rik; Ldlrad4; low density lipoprotein receptor class A domain containing 4; low-density lipoprotein receptor class A domain-containing protein 4; uncharacterized protein C18orf1 homolog | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
753 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunocytochemistry | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
O15165 | |
LDLRAD4 | |
Recombinant Human LDLRAD4. Recombinant protein control fragment (Product #RP-103591). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction